Financial Summary (All financials)
| In millions, except per share items | Sep-30-22 | Sep-30-21 | Sep-30-20 | Sep-30-19 |
| Revenues | 40.2 | 19.8 | 12.5 | 10.9 |
| Revenue growth | 102.6% | 59.1% | 14.5% | |
| Cost of goods sold | 36.6 | 17.2 | 9.1 | 7.9 |
| Gross profit | 3.6 | 2.6 | 3.4 | 3.0 |
| Gross margin | 9.1% | 13.2% | 26.9% | 27.3% |
| Sales and marketing | 0.1 | 0.2 | 0.1 | 0.3 |
| Research and development | 1.0 | 0.4 | 0.3 | 0.6 |
| General and administrative | 2.1 | 1.4 | 0.9 | 0.9 |
| EBIT | 0.5 | 0.6 | 2.0 | 1.2 |
| EBIT margin | 1.1% | 2.9% | 16.1% | 10.9% |
| Pre-tax income | 2.5 | 1.7 | 2.5 | 1.8 |
| Income taxes | 0.3 | 0.4 | 0.2 | 0.1 |
| Tax rate | 12.4% | 25.2% | 6.8% | 6.1% |
| Net income | 2.2 | 0.3 | 2.3 | 1.7 |
| Net margin | 5.5% | 1.6% | 18.8% | 15.3% |
| |
| Diluted EPS | $0.10 | $0.02 | $0.23 | $0.17 |
| Shares outstanding (diluted) | 21.7 | 15.2 | 10.0 | 10.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|